PRODUCT LITERATURE
An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug‑induced liver injury using a nationwide database
Drug-induced liver injury (DILI) refers to liver damage caused by drugs. DILI poses a significant challenge in
the development of new drugs. The management of DILI mainly involves the withdrawal of the offending drug, and there is
a lack of specific therapy. This study sought to evaluate the efficacy and safety of compound glycyrrhizin (CG) injections in
DILI patients. Aim To evaluate the efficacy and safety of compound glycyrrhizin injections in DILI treatment
No other version available